Market attractiveness for the IVUS Imaging System for Coronary Artery remains robust, fueled by rising cardiovascular disease prevalence and aging populations. Competitive intensity is moderate, with dominant players like Boston Scientific and Abbott maintaining market share, while niche innovators leverage AI-driven imaging solutions to differentiate. The long-term outlook is optimistic, supported by advancements in image resolution, integration with robotic systems, and expanding adoption in emerging economies. The innovation landscape is dynamic, with a focus on miniaturization, real-time 3D imaging, and cloud-based data analytics. Demandโsupply balance is currently favorable, though potential bottlenecks in high-end systems could arise due to R&D delays. Key risk factors include regulatory hurdles, reimbursement policy shifts, and supply chain vulnerabilities. This IVUS Imaging System for Coronary Artery market outlook highlights a trajectory of growth, where strategic partnerships and AI-centric R&D will define leadership in the next decade.